Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention

This publication has 28 references indexed in Scilit:

• Scientific and therapeutic advances in antiplatelet therapy
  Nature Reviews Drug Discovery, 2003
• Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
  JAMA, 2002
• Death Following Creatine Kinase-MB Elevation After Coronary Intervention
  Circulation, 2002
• Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P‐selectin expression in a human ex vivo in vitro model
  Clinical Pharmacology & Therapeutics, 2002
• CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
  Nature Medicine, 2002
• Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel
  Platelets, 2001
• Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis
  Heart, 2000
• Requirement for CD154 in the progression of atherosclerosis
  Nature Medicine, 1999
• Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina
  Circulation, 1999
• Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA.
  Circulation, 1993